Cardiomix

Curated by Signal

Provider of AI-based platform for cardiac disease diagnosis

Overview

Provider of AI-based platform for cardiac disease diagnosis. It offers a genomics-based medical device with cloud analytics and database to detect circulating biomarkers for cardiomyopathies and arrhythmogenic disorders.

Key facts

Founded: 2019
Headquarters: Milan, Italy
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

3 products and services: Sign up to view

Contact

Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

AMID
Quantitative analysis of medical cardiovascular imaging
Life Sciences TechnologySulmona, Italy
Micromed
Developer of medical devices for neuroimaging
Life Sciences TechnologyMogliano Veneto, Italy
EVVIVAX
Developer of nucleic-acid-based immunotherapies
Life Sciences TechnologyRome, Italy

About Cardiomix

What does Cardiomix do?

Provider of AI-based platform for cardiac disease diagnosis.

Where is Cardiomix headquartered?

Cardiomix is headquartered in Milan, Italy.

When was Cardiomix founded?

Cardiomix was founded in 2019.

Which sector is Cardiomix in?

Cardiomix operates in Life Sciences Technology.

Who are Cardiomix's competitors?

Companies similar to Cardiomix include AMID, Micromed, and EVVIVAX.